Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Inflammation & Immunology Breakthrough: Molecular glues for the selective elimination of pathogenic macrophages
Yingqun Huang, PhD -
First-in-class antibody targeting NETosis
James E. Hansen, MD, MS -
Resetting the immune system for autoimmune and inflammatory diseases
Carrie L Lucas, PhD -
Small Molecule Incretin Hormone Amplifier for the Treatment of Obesity and Diabetes
Richard Kibbey, MD/PhD -
Targeting genetically associated childhood and adult obesity
Demetrios Braddock, MD, PhD -
Generation of a humanized antibody with a proven effect for the prevention of Thoracic and abdominal Aortic aneurysm Dissection in mice
Arya Mani, MD, FACC, FAHA -
Therapeutic targeting of protocadherin gamma A9 (Pcdhga9)
Martin Schwartz, PhD -
Evershield: Long-acting, biodegradable implants for local, sustained drug release
W. Mark Saltzman, Ph.D. -
B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastases
Ranjit S. Bindra, M.D., Ph.D. -
Brain Endothelium-Targeted Therapy for Cerebral Cavernous Malformations
Jaime Grutzendler, MD